Form 8-K - Current report:
SEC Accession No. 0001193125-21-019329
Filing Date
2021-01-27
Accepted
2021-01-27 17:23:54
Documents
17
Period of Report
2021-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120864d8k.htm   iXBRL 8-K 29730
2 EX-1.1 d120864dex11.htm EX-1.1 206277
3 EX-5.1 d120864dex51.htm EX-5.1 8940
4 EX-99.1 d120864dex991.htm EX-99.1 8262
8 GRAPHIC g120864g0127085756863.jpg GRAPHIC 1595
9 GRAPHIC g120864g0128025037343.jpg GRAPHIC 2353
  Complete submission text file 0001193125-21-019329.txt   450033

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210126.xsd EX-101.SCH 3102
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210126_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210126_pre.xml EX-101.PRE 11429
10 EXTRACTED XBRL INSTANCE DOCUMENT d120864d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21561002
SIC: 2834 Pharmaceutical Preparations